Humira (adalimumab) and Remicade (infliximab) are prescription drugs used to treat certain inflammatory conditions. Humira is given as an injection, while Remicade is given as an infusion. Humira and ...

Jan. 2, 2003 — Abbott Laboratories received U.S. Food and Drug Administration (FDA) approval this week to market adalimumab (Humira), previously known as D2E7. The drug was approved for the treatment ...

Biosimilars demonstrate comparable drug survival and safety with adalimumab among new users, but patients switching from Humira (the originator product) to biosimilars had a 35% higher discontinuation ...

Please provide your email address to receive an email when new articles are posted on . The risks for major adverse cardiac events and malignancy, excluding non-melanoma skin cancer, are similar ...